TN2013000135A1 - Solid state forms of a potent hcv inhibitor - Google Patents

Solid state forms of a potent hcv inhibitor

Info

Publication number
TN2013000135A1
TN2013000135A1 TNP2013000135A TN2013000135A TN2013000135A1 TN 2013000135 A1 TN2013000135 A1 TN 2013000135A1 TN P2013000135 A TNP2013000135 A TN P2013000135A TN 2013000135 A TN2013000135 A TN 2013000135A TN 2013000135 A1 TN2013000135 A1 TN 2013000135A1
Authority
TN
Tunisia
Prior art keywords
solid state
state forms
hcv inhibitor
potent hcv
potent
Prior art date
Application number
TNP2013000135A
Other languages
French (fr)
Inventor
Rolf-Stefan Brickl
Shirlynn Chen
Jihchin Chung
Mayur Suryakant Dudhedia
Danping Li
Siddharthya Mujumdar
Chitra Telang
Richard Varsolona
Zeren Wang
Zhi-Hui Lu
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2011/052869 external-priority patent/WO2012044520A1/en
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of TN2013000135A1 publication Critical patent/TN2013000135A1/en

Links

Abstract

This invention relates to novel sodium salt forms of the following Compound (1), and methods for the preparation thereof, pharmaceutical compositions thereof, and their use in the treatment of Hepatitis C Viral (HCV) infection.
TNP2013000135A 2011-09-23 2013-03-27 Solid state forms of a potent hcv inhibitor TN2013000135A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2011/052869 WO2012044520A1 (en) 2010-09-30 2011-09-23 Solid state forms of a potent hcv inhibitor

Publications (1)

Publication Number Publication Date
TN2013000135A1 true TN2013000135A1 (en) 2014-06-25

Family

ID=54360803

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2013000135A TN2013000135A1 (en) 2011-09-23 2013-03-27 Solid state forms of a potent hcv inhibitor

Country Status (1)

Country Link
TN (1) TN2013000135A1 (en)

Similar Documents

Publication Publication Date Title
MY153093A (en) Crystalline forms of a 2-thiazolyl-4-quinolinyl-oxy derivative, a potent hcv inhibitor
EA026667B9 (en) Pharmaceutical composition for treating hepatitis c virus
PH12015502056A1 (en) Benzothiazole compounds and their pharmaceutical use
UA113956C2 (en) PIRIMIDIN DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS
PH12014501134B1 (en) 2',4'-difluoro-2'-methyl substituted nucleoside derivatives as inhibitors of hcv rna replication
MD20140136A2 (en) Inhibitors of hepatitis C virus
MX2012015293A (en) 2 -quinolinyl- acetic acid derivatives as hiv antiviral compounds.
TN2012000358A1 (en) Hepatitis c virus inhibitors
EP2555622A4 (en) Hepatitis c virus inhibitors
UA116083C2 (en) Purine derivatives for the treatment of viral infections
HK1166788A1 (en)
MY160130A (en) Hepatitis c virus inhibitors
MX2012008221A (en) Inhibitors of flaviviridae viruses.
MX2012008211A (en) Inhibitors of flaviviridae viruses.
MX2012015097A (en) Napht- 2 -ylacetic acid derivatives to treat aids.
PH12014501283A1 (en) 4`-azido, 3``-fluoro substituted nucleoside derivatives as inhibitors of hcv rna replication
GEP20156263B (en) Substituted azoles, anti-viral active ingredient, pharmaceutical composition, method for production and usage thereof
IN2012DN01855A (en)
MX337936B (en) Hepatitis c virus inhibitors.
WO2013059278A3 (en) Hepatitis c virus inhibitors
MY167881A (en) Process for preparing antiviral compounds
WO2011150190A3 (en) Hcv inhibitor compounds and methods of use thereof
BR112013028679A2 (en) hepatitis c virus inhibitors
JO3281B1 (en) Benzofuran Compounds for the Treatment of Hepatitis C Virus Infections
MX360161B (en) Process for preparing antiviral compounds.